Aptar Pharma Promotes Latest Injectable Developments at PDA Annual Meeting 2018
Press Release | Aptar Pharma
MARCH 15, 2018
Crystal Lake, Illinois: – Aptar Pharma, a leading provider of innovative drug delivery systems, is pleased to once again be an exhibitor at the 2018 PDA Annual Meeting, taking place on March 19-21 in Orlando, Florida.
The 2018 PDA Annual Meeting presents pharma professionals with the opportunity to gain unique insights into industry advancements in processing, manufacturing and quality control, as well as developments for new pharmaceutical and biopharmaceutical products. Delegates also have access to plenary sessions focused on future trends, disruptive technologies and patient centricity.
Aptar Pharma experts will showcase the latest developments in its Premium product portfolio of PremiumFill®, PremiumCoat™ and PremiumVision™ at Stand No. 406, demonstrating its response to the need for higher quality standards within elastomer components.
Additionally, Next Breath, an Aptar Pharma business, will showcase its analytical services. The company has recently expanded to include development services for injectable delivery systems, with a core focus on extractables and leachables profiling. Attendees can learn more about how Next Breath can help to guide them through the quality requirement increases for component qualification, validation and regulatory compliance.
About Aptar Pharma
Aptar Pharma is part of AptarGroup, Inc., a leading global supplier of a broad range of innovative dispensing and sealing solutions for the beauty, personal care, home care, prescription drug, consumer health care, injectables, food and beverage markets. AptarGroup is headquartered in Crystal Lake, Illinois, with manufacturing facilities in North America, Europe, Asia and South America.
For more information, visit: www.aptar.com/pharma.
To connect with Aptar Pharma and meet our team of experts, Register now at 2018 PDA Annual Meeting.
Click on Aptar Pharma Promotes Latest Injectable Developments for other information.
Click on Aptar Pharma to contact the company directly.